86 related articles for article (PubMed ID: 18384260)
21. Pharmacogenetics in drug discovery and development: a translational perspective.
Roses AD
Nat Rev Drug Discov; 2008 Oct; 7(10):807-17. PubMed ID: 18806753
[TBL] [Abstract][Full Text] [Related]
22. Evolution of pharmacogenomics.
Somogy A
Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663
[TBL] [Abstract][Full Text] [Related]
23. SNPs and haplotypes: genetic markers for disease and drug response (review).
Shastry BS
Int J Mol Med; 2003 Mar; 11(3):379-82. PubMed ID: 12579344
[TBL] [Abstract][Full Text] [Related]
24. Designing pharmacogenetic projects in industry: practical design perspectives from the Industry Pharmacogenomics Working Group.
Bromley CM; Close S; Cohen N; Favis R; Fijal B; Gheyas F; Liu W; Lopez-Correa C; Prokop A; Singer JB; Snapir A; Tchelet A; Wang D; Goldstaub D;
Pharmacogenomics J; 2009 Feb; 9(1):14-22. PubMed ID: 18794908
[TBL] [Abstract][Full Text] [Related]
25. Pharmacogenetics: from bench to byte.
Swen JJ; Wilting I; de Goede AL; Grandia L; Mulder H; Touw DJ; de Boer A; Conemans JM; Egberts TC; Klungel OH; Koopmans R; van der Weide J; Wilffert B; Guchelaar HJ; Deneer VH
Clin Pharmacol Ther; 2008 May; 83(5):781-7. PubMed ID: 18253145
[TBL] [Abstract][Full Text] [Related]
26. How molecular medicine transforms policy (and everything else).
Kean MA; Batchelder KF
J Biolaw Bus; 2004; 7(3):16-9. PubMed ID: 15460603
[TBL] [Abstract][Full Text] [Related]
27. Advances in Target Validation--SMi third annual conference: 7-8 April 2003, London, UK.
Gravenstede S
IDrugs; 2003 Jun; 6(6):563-5. PubMed ID: 12861986
[No Abstract] [Full Text] [Related]
28. Introducing pharmacogenetic testing with clinical decision support into primary care: a feasibility study.
Dawes M; Aloise MN; Ang JS; Cullis P; Dawes D; Fraser R; Liknaitzky G; Paterson A; Stanley P; Suarez-Gonzalez A; Katzov-Eckert H
CMAJ Open; 2016; 4(3):E528-E534. PubMed ID: 27730116
[TBL] [Abstract][Full Text] [Related]
29. EPIDAUROS Biotechnologie AG.
Arnold HP; Kluge P; Mauch S
Pharmacogenomics; 2005 Jul; 6(5):535-8. PubMed ID: 16014003
[TBL] [Abstract][Full Text] [Related]
30. Personalized medicine.
Jain KK
Curr Opin Mol Ther; 2002 Dec; 4(6):548-58. PubMed ID: 12596356
[TBL] [Abstract][Full Text] [Related]
31. Assessing patient readiness for the clinical adoption of personalized medicine.
Issa AM; Tufail W; Hutchinson J; Tenorio J; Baliga MP
Public Health Genomics; 2009; 12(3):163-9. PubMed ID: 19204419
[TBL] [Abstract][Full Text] [Related]
32. Clinical usefulness of electronic drug-drug interaction checking in the care of cardiovascular surgery inpatients.
Taegtmeyer AB; Kullak-Ublick GA; Widmer N; Falk V; Jetter A
Cardiology; 2012; 123(4):219-22. PubMed ID: 23208189
[TBL] [Abstract][Full Text] [Related]
33. Come Dance With Me: Transformative Changes in the Science and Practice of Drug-Drug Interactions.
Venkatakrishnan K; Rostami-Hodjegan A
Clin Pharmacol Ther; 2019 Jun; 105(6):1272-1278. PubMed ID: 31004453
[TBL] [Abstract][Full Text] [Related]
34. Raju Kucherlapati talks about personalised medicine: breathing new life into old drugs. Interview by Steve Carney.
Kucherlapati R
Drug Discov Today; 2007 Apr; 12(7-8):272-5. PubMed ID: 17458021
[No Abstract] [Full Text] [Related]
35. Applying technologies towards safe and effective medicines.
Roses AD
Biotechniques; 2005 Oct; 39(4):563-4. PubMed ID: 16235568
[No Abstract] [Full Text] [Related]
36. Pharmacogenetics and personalized medicine: the future for drug prescribing.
Mitri Z; Esmerian MO; Simaan JA; Sabra R; Zgheib NK
J Med Liban; 2010; 58(2):101-4. PubMed ID: 20549897
[TBL] [Abstract][Full Text] [Related]
37. Perlegen sciences, inc.
Peacock E; Whiteley P
Pharmacogenomics; 2005 Jun; 6(4):439-42. PubMed ID: 16004563
[TBL] [Abstract][Full Text] [Related]
38. Novel technology and the development of pharmacogenetics within the pharmaceutical industry.
Gibson N; Jawaid A; March R
Pharmacogenomics; 2005 Jun; 6(4):339-56. PubMed ID: 16004553
[TBL] [Abstract][Full Text] [Related]
39. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).
Roses AD; Saunders AM; Huang Y; Strum J; Weisgraber KH; Mahley RW
Pharmacogenomics J; 2007 Feb; 7(1):10-28. PubMed ID: 16770341
[TBL] [Abstract][Full Text] [Related]
40. Pharmacogenetics and drug metabolism.
Ball S; Borman N
Nat Biotechnol; 1997 Oct; 15(10):925-6. PubMed ID: 9335033
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
